Abstract
Angiotensin (Ang)-(1–7) is one of the major active components of the renin-angiotensin system, produced from cleavage of Ang II by angiotensin-converting-enzyme type 2 (ACE2), which acts through a specific G protein-coupled receptor, Mas. We have investigated whether the human endometrium expresses these components during menstrual cycle. By radioimmunoassay, Ang-(1–7) was detected in endometrial wash fluid at picomolar concentrations. Using immunofluorescence, both the peptide and its receptor were identified in cultured endometrial epithelial and stromal cells. By immunohistochemistry, Ang(1–7) was localized in the endometrium throughout menstrual cycle, being more concentrated in the glandular epithelium of mid- and late secretory phase. This pattern corresponded to the ACE2 mRNA, which was more abundant in epithelial cells than in stromal cells (2-fold increase, p < 0.05) and in the secretory vs. proliferative phase (6.6-fold increase, p < 0.01). The receptor Mas was equally distributed between epithelial and stromal cells and did not change during menstrual cycle. The physiological role of this peptide system in normal and pathological endometrium warrants further investigation.
Similar content being viewed by others
References
Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest. 1987;79:1–6.
Reudelhuber TL. A place in our hearts for the lowly angiotensin 1–7 peptide? Hypertension. 2006;47:811–815.
Peach MJ. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev. 1977;57:313–370.
Nakashima H, Suzuki H, Ohtsu H, et al. Angiotensin II regulates vascular and endothelial dysfunction: recent topics of Angiotensin II type-1 receptor signaling in the vasculature. Curr Vasc Pharmacol. 2006;4:67–78.
Le Noble FA, Schreurs NH, van Straaten HW, et al. Evidence for a novel angiotensin II receptor involved in angiogenesis in chick embryo chorioallantoic membrane. Am J Physiol. 1993;264:R460-R465.
Fernandez LA, Twickler J, Mead A. Neovascularization produced by angiotensin II. J Lab Clin Med. 1985;105:141–145.
Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci USA. 1996;93:156–160.
Goldenberg I, Grossman E, Jacobson KA, Shneyvays V, Shainberg A. Angiotensin II-induced apoptosis in rat cardiomyocyte culture: a possible role of AT1 and AT2 receptors. J Hypertens. 2001;19:1681–1689.
Ferris TF, Gorden P, Mulrow PJ. Rabbit uterus as a source of renin. Am J Physiol. 1967;212:698–702.
Shaw KJ, Do YS, Kjos S, et al. Human decidua is a major source of renin. J Clin Invest. 1989;83:2085–2092.
Shah DM, Higuchi K, Inagami T, Osteen KG. Effect of progesterone on renin secretion in endometrial stromal, chorionic trophoblast, and mesenchymal monolayer cultures. Am J Obstet Gynecol. 1991;164:1145–1150.
Ahmed A, Li XF, Shams M, et al. Localization of the angiotensin II and its receptor subtype in human endometrium and identification of a novel high-affinity angiotensin II binding site. J Clin Invest. 1995;96:848–857.
Saridogan E, Dahanbakhch O, Puddefoot JR, et al. Type1 angiotensin II receptor in human endometrium. Human Reprod. 1996;2:659–664.
Li XF, Ahmed A. Compartmentalization and cyclic variation of immunoreactivity of renin and angiotensin converting enzyme in human endometrium throughout the menstrual cycle. Hum Reprod. 1997;12:2804–2809.
Li XF, Ahmed A. Expression of angiotensin II and its receptor subtypes in endometrial hyperplasia: a possible role in dysfunctional menstruation. Lab Invest. 1996;75:137–145.
Ferrario CM, Chappell MC, Tallant EA, Brosnihan KB, Diz DI. Counter-regulatory actions of angiotensin-(1–7). Hypertension. 1997;30:535–541.
Santos RA, Ferreira AJ, Simões e Silva AC. Recent advances in the angiotensin-converting enzyme 2-angiotensin(1–7)-Mas axis. Exp Physiol. 2008;93:519–527.
Donoghue M, Hsieh F, Baronas E, et al. A novel angiotensin-convertingenzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1–9. Circ Res. 2000;87:E1–E9.
Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem. 2000;275:33238–33243.
Santos RAS, Simoes e Silva AC, Maric C, et al. Angiotensin(1–7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA. 2003;100:8258–8263.
Freeman EJ, Chisolm GM, Ferrario CM, Tallant EA. Angiotensin-(1–7) inhibits vascular smooth muscle cell growth. Hypertension. 1996;28:104–108.
Tallant EA, Diz DI, Ferrario CM. State-of-the-Art lecture. Antiproliferative actions of angiotensin-(1–7) in vascular smooth muscle. Hypertension. 1999;34:950–957.
Strawn WB, Ferrario CM, Tallant EA. Angiotensin-(1–7) reduces smooth muscle growth after vascular injury. Hypertension. 1999;33:207–211.
Tallant EA, Clark MA. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1–7). Hypertension. 2003;42: 574–579.
Anton L, Merrill DC, Neves LA, Brosnihan KB. Angiotensin-(1–7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1–7) receptor. Endocrine. 2007;32:212–218.
Sampaio WO, Henrique de Castro C, Santos RA, Schiffrin EL, Touyz RM. Angiotensin-(1–7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension. 2007;50:1093–1098.
Sampaio WO, Santos RA, Faria-Silva R, da Mata Machado LT, Schiffrin EL, Touyz RM. Angiotensin-(1–7) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension. 2007;49:185–192.
Simoes e Silva AC, Diniz JS, Regueira-Filho A, Santos RA. The renin angiotensin system in childhood hypertension: selective increase of angiotensin-(1–7) in essential hypertension. J Pediatr. 2004;145:93–98.
Botelho LM, Block CH, Khosla MC, Santos RA. Plasma angiotensin(1–7) immunoreactivity is increased by salt load, water deprivation, and hemorrhage. Peptides. 1994;15: 723–729.
da Costa Gonçalves AC, Leite R, Fraga-Silva RA, et al. Evidence that the vasodilator angiotensin-(1–7)-Mas axis plays an important role in erectile function. Am J Physiol Heart Circ Physiol. 2007;293:H2588-H2596.
Becker LK, Etelvino GM, Walther T, Santos RA, Campagnole-Santos MJ. Immunofluorescence localization of the receptor Mas in cardiovascular-related areas of the rat brain. Am J Physiol Heart Circ Physiol. 2007;293:H1416-H1424.
Lucidi RS, Witz CA, Chrisco M, Binkley PA, Shain SA, Schenken RS. A novel in vitro model of the early endometriotic lesion demonstrates that attachment of endometrial cells to mesothelial cells is dependent on the source of endometrial cells. Fertil Steril. 2005;84:16–21.
Catalano RD, Critchley HO, Heikinheimo O, et al. Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007;13:641–654.
Li XF, Ahmed A. Dual role of angiotensin II in the human endometrium. Hum Reprod. 1996;11:95–108.
Neves LA, Stovall K, Joyner J, et al. ACE2 and ANG-(1–7) in the rat uterus during early and late gestation. Am J Physiol Regul Integr Comp Physiol. 2008;294:R151–R161.
Vickers C, Hales P, Kaushik V. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem. 2002;277:14838–14843.
Paizis G, Tikellis C, Cooper ME, et al. Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut. 2005;54:1790–1796.
Kostenis E, Milligan G, Christopoulos A, et al. G-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation. 2005;111:1806–1813.
Simões e Silva AC, Pinheiro SV, Pereira RM, Ferreira AJ, Santos RA. The therapeutic potential of Angiotensin-(1–7) as a novel Renin-Angiotensin System mediator. Mini Rev Med Chem. 2006;6:603–609.
Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450–456.
Sugawara A, Ito S. Stimulatory effects of angiotensin II on angiogenesis. Nippon Rinsho. 2006;64(suppl 5):67–69.
Bonnet F, Cao Z, Cooper ME. Apoptosis and angiotensin II: yet another renal regulatory system? Exp Nephrol. 2001;9:295–300.
Benter IF, Diz DI, Ferrario CM. Cardiovascular actions of angiotensin-(1–7). Peptides. 1993;14:679–684.
Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1–7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension. 1997;29:394–400.
Machado RDP, Santos RAS, Andrade SP. Opposing actions of angiotensins on angiogenesis. Life Sci. 1999;66:67–76.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vaz-Silva, J., Carneiro, M.M., Ferreira, M.C. et al. The Vasoactive Peptide Angiotensin-(1–7), Its Receptor Mas and the Angiotensin-converting Enzyme Type 2 are Expressed in the Human Endometrium. Reprod. Sci. 16, 247–256 (2009). https://doi.org/10.1177/1933719108327593
Published:
Issue Date:
DOI: https://doi.org/10.1177/1933719108327593